Cardiovascular Endpoints



Similar documents
Cardiovascular Endpoints

Malmö Preventive Project. Cardiovascular Endpoints

Malmö Preventive Project. Cardiovascular Endpoints

Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

DIAGNOSTIC CRITERIA OF STROKE

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.


DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA

Physician and other health professional services

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Hospital-based SNF Coding Tip Sheet: Top 25 codes and ICD-10 Chapter Overview

Hormones and cardiovascular disease, what the Danish Nurse Cohort learned us

Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses

African Americans & Cardiovascular Diseases

Medicare Risk Adjustment and You. Health Plan of San Mateo Spring 2009

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

Cancer and Heart/Stroke coverage

Coronary Heart Disease (CHD) Brief

NCD for Lipids Testing

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

Adult Cardiac Surgery ICD9 to ICD10 Crosswalks

Cancer and Heart/Stroke coverage

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN

Chapter 3: Review of Literature Stroke

ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE

APPENDIX A NEUROLOGIST S GUIDE TO USING ICD-9-CM CODES FOR CEREBROVASCULAR DISEASES INTRODUCTION

Design and principal results

International Task Force for Prevention Of Coronary Heart Disease. Clinical management of risk factors. coronary heart disease (CHD) and stroke

Main Effect of Screening for Coronary Artery Disease Using CT

LIPID PANEL CHOLESTEROL LIPOPROTEIN, ELECTROPHORETIC SEPARATION LIPOPROTEIN, DIRECT MEASUREMENT (HDL) LDL DIRECT TRIGLYCERIDES

COPD and cardiovascular diseases (CVDs) are

Aspirin to Prevent Heart Attack and Stroke: What s the Right Dose?

Kawasaki Disease Complicated by Coronary Artery Aneurysms: Mortality and 40-year Outcomes

Prognostic impact of uric acid in patients with stable coronary artery disease

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

Long term care coding issues for ICD-10-CM

LIMITED BENEFIT HEALTH COVERAGE FOR SPECIFIED CRITICAL ILLNESS. OUTLINE OF COVERAGE (Applicable to Policy Form CI-1.0-NC)

Louisiana Report 2013

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study

Automatic External Defibrillators

Stroke Prevention in Primary Care

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015

GENERAL HEART DISEASE KNOW THE FACTS

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November :38

Coding in Germany - The Use of ICD-10 for Diagnoses

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014

At the Heart of the Matter: 2011 Report on Heart Disease and Stroke in Colorado

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators

Critical Illness Insurance

SUPPLEMENTARY MATERIALS. Rivaroxaban for Stroke Prevention in East Asian Patients from the ROCKET AF Trial

RAW PREVALENCE FOR NORTHERN IRELAND AS AT 31 MARCH 2014

Ischemia and Infarction

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Chapter 2: Health in Wales and the United Kingdom

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

EXHIBIT H SETTLEMENT ELIGIBILITY CRITERIA. a) pharmacy records reflecting the dispensing of Bextra and/or Celebrex to the Class Member; or

Service Specification Template Department of Health, updated June 2015

on a daily basis. On the whole, however, those with heart disease are more limited in their activities, including work.

CCG Outcomes Indicator Set: Emergency Admissions

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology

Diabetes Mellitus and the Circulatory System

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Epidemiology of Hypertension 陈 奕 希 李 禾 园 王 卓

DEPARTMENT OF VETERANS AFFAIRS Veterans Benefits Administration Washington, D.C All VA Regional Offices and Centers Fast Letter 14-08

Breaking the Code: ICD-9-CM Coding in Details

Long-term effects of adjuvant tamoxifen treatment on cardiovascular disease and cancer

Addendum to Clinical Review for NDA

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES

How To Pay For Critical Illness Insurance From The Ihc Group

Local Coverage Article: NCD Coding Article for Positron Emission Tomography (PET) Scans Used for Non- Oncologic Conditions (A53134)

Multimorbidity in patients with type 2 diabetes mellitus in the Basque Country (Spain)

Long-term consequence of injury on self-rated health

Critical Illness Insurance. Second Chance for Children 30 days to 17 years

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Swedish Initiative for Research on Microdata in the Social And Medical Sciences

Critical Illness Supplemental Insurance

Surgeons Role in Atrial Fibrillation

Table e-1: Description of the three participating centres Umeå, Sweden Dublin, Ireland Barcelona, Spain Population-based study with single

Table 1 Performance Measures. Quality Monitoring P4P Yr1 Yr2 Yr3. Specification Source. # Category Performance Measure

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE

The Independent Order Of Foresters ( Foresters ) Critical Illness Rider (Accelerated Death Benefit) Disclosure at the Time of Application

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

PROTOCOL ACTION FOR HEALTH IN DIABETES. Look AHEAD. Clinical Trial

Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου

Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study

Effects of Cholesterol and Inflammation-Sensitive Plasma Proteins on Incidence of Myocardial Infarction and Stroke in Men

Understanding Mortality Statistics: The Importance of Cause-of-Death Certification and Coding

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa Objectives. No disclosures, no conflicts

Critical Illness Insurance

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

Impact of Massachusetts Health Care Reform on Racial, Ethnic and Socioeconomic Disparities in Cardiovascular Care

Statins and Risk for Diabetes Mellitus. Background

Transcription:

The Malmö Diet and Cancer Study Department of Clinical Sciences Skåne University Hospital, Malmö Lund University The Malmö Diet and Cancer Study CV-cohort Cardiovascular Endpoints End of follow-up: 30 June Report: 7 October 2011 Anders Dahlin Bo Hedblad (coronary events and stroke) Gunnar Engström (heart failure) Olle Melander (atrial fibrillation and flutter)

1. Cohorts Background population: 74 137 Men: 31 513 Women: 42 624 Malmö Diet and Cancer Study (MDC) cohort Individuals qualify to the MDC cohort if they participated in at least one part of the Malmö Diet and Cancer Study. Total: 30 446 Men: 12 120 Women: 18 326 Cardiovascular (CV) cohort Every other individual in the MDC cohort screened between 1991 to 1994 was invited to a CV project which included a B-mode carotid ultrasound examination for determination of carotid intima-media thickness and plaques. Out of 6 103 individuals which accepted the invitation about 5 500 further participated in an extended examination, including laboratory analyses. Total: 6 103 Men: 2 572 Women: 3 531 Amendments and implementation of new procedures 2011 - Information of reused (återanvända) Personal Identity Numbers (PIN) was taken into account, diagnoses appearing after the date of death of an MDC participating individual were removed. - For individuals with changed PINs, data with the new PIN (death, emigration) were included in the endpoint update. - Date of death as given by SCB has been used (previously dates from SoS were used) - One individual in the MDC cohort (not in CV cohort) was identified with two different PINs, the latest PIN was removed. The new MDC cohort number is 30 446. 2

2. Time of follow-up From date of entry to death, lost to follow-up or to 30 June. Population Person-years MDC cohort * 431 435 Men 168 463 Women 262 971 CV cohort 93 726 Men 38 553 Women 55 173 * Six individuals (3 males, 3 females) out of 30 446 lack follow-up time due to missing screening date. 3

3. Coronary events by diagnosis Number of individuals with first prevalent and/or first incident coronary events until 30 June in the MDC and CV cohorts by diagnosis group. Prevalent: date of diagnosis date of entry Incident: date of diagnosis > date of entry MDC cohort (n=30 446) CV cohort (n=6 103) Diagnosis ICD-9 Prevalent Incident Incident Prevalent Incident Incident Acute myocardial infarction 410 600 2209 96 102 436 18 Other acute and subacute forms of 411 3 ischemic heart disease Old myocardial infarction 412 10 Angina pectoris 413 1 Other forms of chronic ischemic 414 310 13 55 2 heart disease Total 600 2533 109 102 491 20 4. Stroke events by diagnosis Number of individuals with first prevalent and/or first incident stroke events until 30 June in the MDC and CV cohorts by diagnosis group. MDC cohort (n=30 446) CV cohort (n=6 103) Diagnosis ICD-9 Prevalent Incident Incident Unknown - 14 31 3 6 Prevalent Incident Incident Subarachnoid hemorrhage 430 49 69 7 13 Intracerebral hemorrhage 431 35 251 3 3 47 Occlusion of cerebral arteries 434 206 1693 43 30 321 14 Acute, but ill-defined, 436 40 25 1 5 4 cerebrovascular disease Total 344 2069 47 48 391 14 4

5. Heart failure events by diagnosis Number of individuals with first prevalent and/or first incident heart failure events until 30 June in the MDC and CV cohorts by diagnosis group. MDC cohort (n=30 446) CV cohort (n=6 103) Diagnosis ICD-9/ Prevalent * Incident * Incident Prevalent * Incident * Incident ICD-10 pre post pre post pre post pre post MI MI MI MI MI MI MI MI Heart failure 428 57 30 724 301 59 8 5 144 49 8 Hypertensive heart disease I11.0 8 3 1 1 1 with (congestive) heart failure Total 57 30 732 304 60 8 5 144 50 9 * Prevalent and incident heart failure events were splitted into following groups: Pre MI = heart failure at least one day before a possible acute myocardial infarction Post MI = heart failure on the same day or after a non-fatal acute myocardial infarction (incl. possible prevalent MI) Acute myocardial infarction were identified through ICD8/9=410 and ICD10=I21 in the Hospital Discharge Register 6. Atrial fibrillation and flutter events by diagnosis Number of individuals with first prevalent or first incident atrial fibrillation and flutter events until 30 June in the MDC and CV cohorts. Only the first event of an individual is recorded, thus no incident event is recorded if the individual has a prevalent event. MDC cohort (n=30 446) CV cohort (n=6 103) Diagnosis ICD-9 Prevalent Incident Incident Prevalent Incident Incident Atrial fibrillation and flutter 427D 312 2364 175 58 476 36 5

7. Incident cardiovascular events by year of diagnosis Number of individuals with first incident coronary, stroke, heart failure and/or atrial fibrillation/ flutter events until 30 June in the MDC and CV cohorts by year of diagnosis. Coronary events Stroke Heart failure * Atrial fibrillation/ flutter ** Year MDC CV MDC CV MDC CV MDC CV Pre MI Post MI Pre MI Post MI 1991 3 2 1 1992 9 6 12 4 2 2 1 2 5 1993 29 10 21 8 5 2 2 1 16 6 1994 50 17 47 17 9 1 7 1 31 17 1995 97 19 74 20 25 6 7 2 42 15 1996 128 24 94 14 26 13 7 2 68 14 1997 128 24 103 20 25 11 6 1 85 20 1998 146 25 117 17 29 14 6 92 16 1999 154 27 120 25 36 13 8 4 95 18 2000 149 28 144 37 49 17 8 1 109 18 2001 152 24 146 27 40 8 8 106 18 2002 165 33 151 29 49 11 6 4 150 31 2003 200 44 152 30 41 27 6 4 172 39 2004 194 26 139 23 64 31 14 5 232 50 2005 195 46 162 30 59 32 11 6 228 41 2006 200 32 200 30 71 32 16 3 247 47 2007 216 39 159 25 69 26 6 6 223 27 2008 209 47 179 21 89 42 18 6 287 63 109 20 47 14 44 16 7 2 175 36 Total 2533 491 2069 391 732 304 144 50 2364 476 * Incident heart failure events were splitted into following groups: Pre MI = heart failure at least one day before a possible acute myocardial infarction Post MI = heart failure on the same day or after a non-fatal acute myocardial infarction (incl. possible prevalent MI) Acute myocardial infarction were identified through ICD8/9=410 and ICD10=I21 in the Hospital Discharge Register ** No incident atrial fibrillation/flutter event is recorded if the individual has a prevalent event 6

8. Incident coronary events by diagnosis and source Number of individuals with first incident coronary event until 30 June in the MDC cohort by diagnosis group and source of information. Diagnosis ICD-9 Hospital Discharge Register Cause-ofdeath Register Total Acute myocardial infarction 410 1907 302 2209 Other acute and subacute forms of 411 3 3 ischemic heart disease Old myocardial infarction 412 10 10 Angina pectoris 413 1 1 Other forms of chronic ischemic 414 310 310 heart disease Total 1907 626 2533 9. Incident stroke events by diagnosis and source Number of individuals with first incident stroke event until 30 June in the MDC cohort by diagnosis group and source of information. Diagnosis ICD-9 Stroma register (not in HDR) * Stroma register (also in HDR) * HDR, outside Malmö * Recidiv register Unknown - 31 31 Total Subarachnoid hemorrhage 430 3 50 16 69 Intracerebral hemorrhage 431 20 211 20 251 Occlusion of cerebral arteries 434 207 1379 107 1693 Acute, but ill-defined, 436 10 6 9 25 cerebrovascular disease Total 240 1646 152 31 2069 * HDR = Hospital Discharge Register 7

10. Incident heart failure events by diagnosis and source Number of individuals with first incident heart failure event until 30 June in the MDC cohort by diagnosis group and source of information. Diagnosis ICD-9/ Hospital Discharge Register * Total ICD-10 Pre MI Post MI Heart failure 428 724 301 1025 Hypertensive heart disease with I11.0 8 3 11 (congestive) heart failure Total 732 304 1036 * Incident heart failure events were splitted into following groups: Pre MI = heart failure at least one day before a possible acute myocardial infarction Post MI = heart failure on the same day or after a non-fatal acute myocardial infarction (incl. possible prevalent MI) Acute myocardial infarction were identified through ICD8/9=410 and ICD10=I21 in the Hospital Discharge Register 11. Incident atrial fibrillation and flutter events by diagnosis and source Number of individuals with first incident atrial fibrillation and flutter event until 30 June in the MDC cohort by diagnosis group and source of information. Only the first event of an individual is recorded, thus no incident event is recorded if the individual has a prevalent event. Diagnosis ICD-9 Hospital Discharge Register Cause-ofdeath Register Total Atrial fibrillation and flutter 427D * 2348 16 2364 * Corresponding code in the Cause-of-death Register is 4273 8